Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104725409A reveals novel iridium catalysis for high-purity aryl borate. Enables cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.